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Abstract
We compare health care inequity in Japan with that in other OECD countries in
2002 and 2003. To overcome Japanese data problems, we conducted an original
survey. Although some problems remain, we obtained internationally comparable
results on health care inequity for Japan. We test the utilization measure by the
number of outpatients, the number of days of inpatient utilization in the previous
year, out-of-pocket payments in the previous year and other measures, such as a
yes/no indicator for outpatient or inpatient utilization in a lifetime. The results
show that there is no inequity in outpatient or inpatient utilization, but out-of-
pocket payments show significant pro-rich inequity.
Keywords: Horizontal Inequity, Japan, International Comparisons, Concentra-
tion Index, Kakwani Index, Needs
1 Introduction
Inequity in health care has recently become one of the most pertinent and relevant
issues in health economics and health policy. Much research on methodology and
international comparisons has been carried out by Wagstaff et al. (1989, 1991),
Van Doorslaer and Wagstaff (1992), Wagstaff and Van Doorslaer (1993, 1994),
Van Doorslaer et al. (1997, 2000), and Kakwani et al. (1997). In particular,
research on horizontal inequity has been undertaken by Van Doorslaer et al.
(2000) and, most recently, by Wagstaff and Van Doorslaer (2000).
Eleven OECD countries have been studied on the basis of reasonably compa-
rable definitions of health inequity. Unfortunately, Japan has not been included
in previous studies. While Ohkusa and Honda (2003a) use the Comprehensive
Survey of Living Conditions for Japan (CSLC), this survey only reports whether
individuals are currently visiting a doctor, rather than the frequency of visits to
a doctor or hospitalization during the previous year, as surveys for other OECD
countries do. Unfortunately, no national survey contains both this information
and other socio-demographic information. Hence, an original survey is needed.
Mainly due to financial limitations, the sample size of our original survey was far
less than that of a national survey. However, it may still be representative even
though it uses two-stage strata, as does the CSLC. Our survey supplements the
CSLC and is comparable with those for other countries.
We performed the survey in March of 2002 and 2003, and we obtained about
3,000 observations. There were various reasons why we could not complete the
survey in one phase. The most important reason was financial difficulty. We
had funds to survey about 1,500 individuals in one year but it was insufficient to
survey 3,000 individuals. Fortunately, the funding was available in the succeeding
year and thus we could survey over two years. The second reason was related to
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some concerns about bias due to the small sample. Of course, we analyzed the
2002 data of our original survey (Ohkusa and Honda 2003b), but some problems
seemed to remain, which might have been due to the small sample or other
survey procedures. To overcome the small sample or other problems, we needed
a more appropriate survey once again. The third reason concerns the definition of
variables that indicate inpatient utilization. In the 2002 survey, we had surveyed
only inpatient utilization in a lifetime until the year of the survey or within a
year. However, in other OECD countries, the number of hospitalized days is also
surveyed and analyzed. Hence, we added some questions about hospitalized days
in the 2003 survey.
Before considering the measurement of health care, the institutional back-
ground in Japan is summarized. In 1961, Japan completed the introduction of
compulsory public health insurance with coverage for all residents. In 1997, a
new law was introduced requiring coinsurance rates of 20% for the employed and
30% for others, such as the self-employed and dependents. For people over 70
years of age, out-of-pocket payments (OPP) are limited to approximately 4000
yen (about US$36 in 2001 prices) per month. However, large firms sometimes
subsidize their employees by reducing their co-payments to less than the legal
requirement. Medical services are provided as welfare to very poor people who
cannot afford to pay the premiums. Thus, everybody can access medical services
in Japan.
The public health insurance system provides reimbursement on a fee-for-
service (FFS) basis. Although the government regulates the price of treatment
and drugs almost every year, it cannot directly control the choice of treatment
and/or drugs, unlike the Utilization Review at Managed Care. Unlike the Na-
tional Health Service (NHS) and Sickness Fund, the insurer cannot control the
budget ex ante.
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There is no regulation of the medical services chosen by patients, as under-
taken by the gatekeeper in the NHS, or different coverage as in the HMO. In
other words, there is no practical difference between general practitioners and
specialists. The coinsurance rate is the same for services provided in hospitals
and clinics (either public or private), but congestion may implicitly impose an
opportunity cost. The number of beds is strictly regulated, but provision of
outpatient services is virtually unregulated.
Private insurance plays only a minor role because public insurance has such
a comprehensive coverage of medical services. Shigeno (2000) shows that private
insurance appears to complement public insurance only through its income effect.
Hence, private insurance in Japan is very different from that in the USA and
European countries, which is why Japan is usually excluded from international
comparisons in health economics.
2 Data
Our original survey was conducted in March of 2002 and 2003 for the whole of
Japan. In 2002, 640 questionnaires were distributed and 570 were completed
and returned, which provided information on about 1,450 adults. In 2003, the
corresponding figures were 900, 783 and 1,596 respectively.
These households voluntarily contracted with the firm that conducted the
survey to complete the various surveys. The households surveyed were randomly
sampled by two-stage strata, but decisions to cooperate were deliberate. There-
fore, particular attention should be paid to the sampling bias that can arise
from this type of sampling. In fact, the survey has no unemployed and few
self-employed respondents, and there is a slight bias towards richer households.
However, this bias could be controlled for by appropriately weighting informa-
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tion. Hence, not only are subsequent regression results weighted by income and
by region, so are the summary statistics. The sample excludes institutionalized
individuals.
Unfortunately, even after combining the two years, our sample of 3,046 re-
spondents is the smallest used for a health care inequity study for any OECD
country. The second smallest is a sample of 3,374 respondents for Sweden used by
Van Doorslaer et al. (2000). Other countries for which sample sizes of less than
4,000 have been used are East Germany (3,844) and Denmark (3,955). These
were conducted in the early 1990s and so could be updated. Although compa-
rable, our data set for Japan is much smaller than the surveys for other OECD
countries. This is due primarily to financial problems, which cannot be fixed in
the short term. Therefore, we have to use our small data set to analyze health
care inequity in Japan, even though smaller samples may lead to bias.
The basic framework of the surveys conducted in the two years are almost
identical. However there are some differences in sampling and in the question-
naire. First, in the 2002 survey, we selected a few prefectures to survey. By
comparison, in 2003, the survey was distributed randomly to the whole of Japan.
Second, the categories of income and OPP are finer in the 2003 survey than in
the 2002 survey; in the first year, there were nine and aright categories in income
and OPP respectively, while in the second year this was changed to 23 and 22
categories respectively. This change may improve the preciseness of income and
OPP, and thus contribute to gaining a more reliable estimator. The third point
concerns days of hospitalization, i.e. the 2002 survey did not ask about this issue,
but the 2003 survey did. Since it is used in OECD studies other than Japan, this
improvement can contribute to be more convenient comparison between Japan
and other OECD countries.
The main variables are defined as follows. Outpatient utilization is defined in
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two ways. The first indicator of outpatient utilization is whether an individual
visited a doctor in the previous year, while the second definition uses the number
of visits. Although the latter is used in international comparisons, the former
is similar and has been used previously (see, e.g., Ohkusa and Honda, 2003a).
Note again that there is no practical difference between general practitioners and
specialists.
Inpatient utilization is defined in a similar way to outpatient utilization, but
we set two reference periods, i.e. utilization in the previous year, which is used
in OECD studies, and utilization in the lifetime until the survey year. Based
on these reference periods, the first indicator of inpatient utilization is whether
an individual was hospitalized in the reference period and the second definition
uses the number of hospitalized days. Hence, we use four types of inpatients
utilization. Hereafter, the difference between reference periods is indicated by a
superscript, i.e. ”Inpatienta” indicates utilization of inpatient service when the
reference duration is the previous year and ”Inpatientb” indicates utilization of
inpatient services when the reference duration is the lifetime until the survey
year.
OPP is defined at the household level. Note that because the questionnaire
defines OPP as payment for medication, it is not limited to co-payments for med-
ical services, but also includes non-prescribed drugs and other medical services
that are not covered by public health insurance. Thus, we assume that its mode
in each category is the number. Since the highest category is open-ended, we use
the same interval as in the second highest category. Income is also measured at
the household level in nine categories. Hence, we make the same adjustment as
for OPP. Moreover, income is adjusted to household structure as follows.
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Adjusted Income =
Income
(Number of Adults + 0.5 Number of Children)0.75
(1)
where children are less than 16 years old. Chronic disease is represented by a
dummy variable that indicates whether individuals suffered from symptoms even
if they were not currently visiting a doctor.
Summary statistics are shown in Table 1. In the previous year, 74% of indi-
viduals visited a doctor and the average number of visits was 10.4, i.e., almost
once a month. On the other hand, about 5.7% of individuals were hospitalized
in the previous year, but about half of the individuals were hospitalized in their
lifetime until the survey year. The hospitalized days reflect such a difference,
i.e. the number of hospitalized days in the lifetime is about ten times larger
than hospitalized days in the previous year. Average OPP per year per capita is
about 60 thousand yen (about $50). Per capita income adjusted for the number
of adults in the household is about 3.2 million-yen (about US$25,000).
3 The Measurement of Horizontal Inequity
In measuring horizontal inequity, three aspects need to be clarified: the definition
of demand for medical care; the definition of needs; and the estimation methods.
The definitions and estimation methods used in this paper are described below.
Social and economic conditions are defined individually by household disposable
income per equivalent adult, as in previous studies.
3.1 Definition of Needs
Concerning the definition of needs, existing studies use incidences of chronic
illness (Van Doorslaer and Wagstaff, 1992) and self-assessment of health (Van
Doorslaer et al., 1997). Conversely, Van Doorslaer and Wagstaff (2000) define
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needs as the estimated demand for medical care, which is explained by self-
assessment of health (SAH) and/or chronic illness, in addition to demographic
characteristics such as age and gender.
In this paper, we define needs as the estimated demand for outpatient or
inpatient services, or the OPP of the ith person, which indicates the ith smallest
amount of income adjusted for household structure, with the dependent variable
Di. The explanatory variables used are age Ai, gender Gi, self-assessment of
health Hi, and chronic disease Si. Thus the estimated equations in the full
version are:
D∗i = α0 +
4X
j
αjAA
j
i +
4X
j
αAGjAjiGi + αGGi +
4X
l
αlHH li + αSSi + εi
Di =
(
1 if D∗i > 0
0 otherwise
(2)
where superscripts indicate dummy variables. Age categories are divided into
years as follows: 16-24, 25-44, 45-64, 65-74, and 75 plus, as in Van Doorslaer et
al. (2000). Since self-assessment of health is classified into five categories, there
are four dummies for this variable.
The model estimated is a heteroscedasticity-consistent probit for whether in-
dividuals utilize outpatient and inpatient services. The predicted probability,
Φ(Dˆi), is interpreted as Needs n in the context of this procedure. For the num-
ber of visits to the doctor or the number of days hospitalized, the negative bi-
nominal model is employed, as in previous research. These utilization variables
are reported on an individual basis, for all household members. Thus, there
may be intra-family correlation through income, lifestyle, or access to medical
institutions. To account for this, we add random household effects to the model.
Since OPP is a continuous variable, we estimate a linear model for the log of
OPP. Since OPP is a household-level variable, we cannot use individual effects.
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3.2 Estimation Method
First, the Concentration Index for medical care or needs is defined following
Kakwani et al. (1997):
2σ2R
µi
µ
= α0 + α1Ri (3)
where µi is the demand for medical care, µ is the average of µi over persons, Ri
is the cumulative proportion up to the ith person in order of income adjusted for
household structure, and σ2R is its variance. The estimated α1 is the Concentration
Index of the demand for medical care. Similarly, the Concentration Index of needs
is defined by replacing µ by n, which is a measure of needs.
Following Wagstaff and Van Doorslaer (2000), the variance of the Concentra-
tion Index is adjusted as follows:
V ar(Concentration Index) =
1
N
{
NX
i=1
fia
2
i − (1 + Concentration Index)2} (4)
at =
µi
µ
(2Ri−1 − Concentration Index) + 2− qi−1 − qi(5)
qi =
1
µ
iX
s=1
µsfs
The horizontal inequity measure is obtained by using the following estimation
method:
2σ2R
"
µi
µ
− ni
n
#
= β0 + β1Ri (6)
V ar(Horizontal Inequity) =
1
N
(
1
N
NX
i=1
(aµi − ani )2 − Horizontal Inequity2
)
(7)
aµi =
µi
µ
(2Ri − 1− Concentration Index forµ) + 2− qµt−1 − qµi
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qi =
1
µ
tX
s=1
µsfs
ani =
ni
n
(2Ri − 1− Concentration Index forn) + 2− qnt−1 − qni
qi =
1
n
tX
s=1
nsfs
The estimated coefficient of β1 is interpreted as horizontal inequity (Wagstaff et
al., 2000, Van Doorslaer et al., 2000).
4 Empirical Results
The first panel in Table 2 shows the empirical results for ”Needs”. Note that these
numbers are the estimated coefficients and not the marginal effects, and hence
they cannot be interpreted directly. It is apparent that SAH and age significantly
affect outpatient utilization, but may not affect inpatient utilization and OPP.
Overall, Wald tests and F tests indicate a good fit.
Table 3 indicates the distribution of actual ”Needs”, while predicted ”Needs”
are shown in Table 2. Actual utilization is higher in the highest and the lowest
income groups, but this is not the case in the predicted Needs. Overall, predicted
Needs do not seem to reflect income classes, except for the highest income class.
The Concentration Index, which measures inequality in utilization, is sum-
marized in the first and third rows of Table 4. Clearly, these numbers indicate no
inequality in utilization in terms of the number of outpatients or inpatient days.
However, there are some progressive cases in the yes/no indicator of outpatient
service or inpatient utilization in the lifetime. Moreover, the Index suggests evi-
dence of progressiveness in OPP. In other words, the rich have tended to spend
more than the poor do. However, since ”Needs” have not been taken into account,
we cannot discuss inequity.
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Figures 1 to 7 show the Concentration Curve of each variable in the case of
the without year dummy. Since these lines measure the deviation of the Concen-
tration Index from the diagonal line, positive (negative) numbers indicate that
the Concentration Curve passes above (below) the diagonal line. Thus, positive
(negative) numbers imply that the poor (rich) have relatively more utilization or
OPP. The Concentration Curve for utilization in Figures 2 to 6 moves around
zero, but the curves in Figure 1 and 7 clearly move below zero. This leads to the
positive Concentration Index in Table 4. These properties are unchanged if year
and/or prefecture dummies are added as explanatory variables in equation (3).
Next, we move to the Kakwani Index, which is the Concentration Index above
minus Needs. Figures 8 to 14 illustrate the difference between the actual utiliza-
tion and Needs. At a glance, the lines in Figures 8 and 14 move below zero, but
in the other figures, the line moves around zero. This is similar to the properties
of Figures 1 to 7.
To confirm and test the impression given by the Figures, we undertake empir-
ical investigations. The bottom row of Table 4 summarizes the empirical results
for β1 in equation (5), and the lower panel summarizes horizontal inequity ad-
justed for regions.
As the results indicate, the null hypothesis of no inequity cannot be rejected
for the number of outpatients and the number of days of inpatient utilization.
However, for the yes/no indicator of outpatients and inpatient utilization in the
lifetime or OPP, the results indicate pro-rich inequity, as suggested by the figures.
In addition, in the case of no year or regional dummies, inpatient utilization in
the previous year indicates pro-rich inequity, even though it does not indicate
any inequality in Table 4. Conversely, the Kakwani Index of OPP without year
and regional dummies indicates inequity, but when we add a year dummy into
equation (5), the index is significantly positive. This may reflect the changing
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measurement in the two survey years. With regional dummies, the magnitudes
are 0.014, 0.028 and 0.082 for outpatients, inpatient in a lifetime and OPP re-
spectively. Without regional dummies, the corresponding magnitudes are 0.020,
0.037 and 0.074. The Kakwani Index of inpatient utilization in the previous year
without year or regional dummies is 0.08, which is very high compared to OPP.
5 Concluding Remarks
We found that the hypothesis that there is no inequity cannot be rejected, and
Japan would have enjoyed one of the greatest degrees of equity in health care
among OECD countries. However, the point estimate for the number of outpa-
tient services without regional dummies (0.0002 to 0.0011) is larger than those
for Spain (-0.0137), Ireland (-0.0098), Italy (-0.0098), and Belgium (-0.0001), and
smaller than those for the UK (0.0074), Canada (0.0072), Greece (0.0273), Aus-
tria (0.0389), Portugal (0.0524), and the USA (0.0532)1). Thus, Japan enjoys the
best equity not only in the statistical sense, but also in the economic sense.
We can compare inpatient utilization measured in days in Japan with other
OECD countries (Van Doorslaer et al., 2000). Our point estimate -0.123 is the
smallest among Belgium, Denmark, Finland, the Netherlands, Sweden, Switzer-
land, the UK and USA2). Thus, Japan has the greatest most pro-poor inequity.
However, the Kakwani Index is not significant in Japan. As Belgium and the
UK have significant pro-poor inequity, the extent of pro-poor inequity in Japan
is behind these countries in the statistical sense.
From this study, we can learn about the huge differences between the yes/no
indicator and the number of utilization days. The yes/no indicator in outpatient
service always indicated pro-rich inequity, but utilization in terms of the number
of outpatients never showed significant inequity. Moreover, yes/no indicators of
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inpatient utilization sometimes showed pro-rich inequity, but the number of days
of inpatient utilization did not. Therefore, our previous research result (Ohkusa
and Honda 2003a), which reported pro-rich inequity before 1997, but equity in
1998 in the yes/no indicator of outpatients, might be misleading for horizontal
inequity in Japan. We cannot reconsider this result as we did not perform a
survey like the one in this study before 1998. Nevertheless, we have to check the
robustness of the result obtained in this research. This remains a topic for future
study.
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Footnotes
1) The figures for other OECD countries are from Van Doorslaer et al. (2001).
They represent utilization as total visits to a physician and incorporate
regional information.
2) The eight OECD countries are from Van Doorslaer et al. (2000) in the case
of inequity adjusted by age, sex, SAH, and a dummy for chronic illness.
For purposes of comparison, we adopt estimated inequity without regional
dummies.
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Table1: Summary Statistics
Average Standard Minimum Maximum
Outpatient
Yes/No .7439265 .4365346 0 1
Number 10.42587 21.04485 0 240
Inpatienta
Yes/No .0574524 .2327432 0 1
Days 2.15856 18.20843 0 365
Inpatientb
Yes/No .4794694 .4997362 0 1
Days 21.66077 59.74993 0 1200
OPP 62155.3 108338.7 652.1186 1096728
Adjusted Income 319.4429 175.1763 0 2500
Chronic disease .0029547 .0542857 0 1
SAH
Excellent .1404 .1207 0 1
Good .2608985 .4391978 0 1
Fair .4805324 .499704 0 1
Poor .1001664 .3002717 0 1
Very Poor .01797 .1328646 0 1
Age class
35-44 .2166776 .4120487 0 1
45-64 .3260013 .4688247 0 1
65-74 .0577807 .2333666 0 1
75- .0541694 .2263888 0 1
Female .5330266 .49899 0 1
Age class in female
35-44 .1041735 .3055357 0 1
45-64 .165626 .3718057 0 1
65-74 .0276043 .1638632 0 1
75- .0364772 .187505 0 1
Note: ”Inpatienta” indicates utilization of inpatient services when the reference
duration is the previous year and ”Inpatientb” indicates utilization of inpatient
services when the reference duration is the lifetime until the survey year.
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Table 2: Estimation Results for Needs
Outpatient Outpatient Inpatienta Inpatienta
Yes/No Number Yes/No Days
Chronic disease -1.045501 ∗ -.2067976 -7.284971
SAH
Good .2249545 ∗ .0529394 .1744287 .0460832
Fair .4127749 ∗∗∗ .2639287 ∗∗∗ .1576405 -.3586596
Poor .9521107 ∗∗∗ .7134136 ∗∗∗ .9689101 ∗∗∗ .8027589 ∗∗
Very Poor .7666047 ∗∗ 1.144656 ∗∗∗ 1.917009 ∗∗∗ 1.976788 ∗∗∗
Age class
35-44 .060803 .0046188 -.1067994 -.7429157 ∗∗
45-64 .1377472 .2943616 ∗∗∗ .1081444 -.4674477
65-74 .62589 ∗∗∗ .6513819 ∗∗∗ .579962 ∗∗ -.1304366
75- .7410975 ∗∗ .8443223 ∗∗∗ .6625701 ∗∗ .2316605
Female .3012328 ∗∗∗ .1603277 ∗∗ .1960088 -1.271226 ∗∗∗
Age class in female
35-44 -.1273943 .1053174 .0281784 1.137019 ∗∗∗
45-64 -.0719006 .036728 -.2641426 1.339137 ∗∗∗
65-74 -.1992257 .268076 ∗∗ -.5192896 1.815664 ∗∗∗
75- .1466648 .1225138 -.0392491 .9183236 ∗∗
year dummy -.1683252 ∗ -.0845568 ∗∗ .2595098 ∗∗
constant .4662105 ∗∗∗ .1183388 -2.576085 ∗∗∗ 4.721294 ∗∗∗
Sample size 3003 2252 3003 110
No. of households 1100 1007 1100 95
log likelihood ? -1538.6975 -7722.81 -577.38673 -428.42406
p-value for Wald test ≤0.0001 ≤0.0001 ≤0.0001 ≤0.0001
(continue)
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Inpatientb Inpatientb OPP
Yes/No Days
SAH
Age class
Age class in female
Chronic disease -.0061803 -.1769932 -.7762752 ∗
Good .2374815 ∗∗ .0142394 -.0170967
Fair .4218254 ∗∗∗ -.0603613 .1687189 ∗∗
Poor .9066628 ∗∗∗ .4318681 ∗∗∗ .6207846 ∗∗∗
Very Poor 1.50387 ∗∗∗ 1.039713 ∗∗∗ 1.055295 ∗∗∗
35-44 .0266897 -.0476653 -.0404152
45-64 .3509446 ∗∗∗ .1987412 ∗ .082979
65-74 1.025813 ∗∗∗ .0819955 .3327759 ∗∗
75- 1.136715 ∗∗∗ .7517713 ∗∗∗ -.0605596
Female -.0471593 -.1521425 -.0702421
35-44 .3058874 ∗∗ .3846519 ∗∗ .0931229
45-64 .2742656 ∗∗ .1867501 .0443513
65-74 -.4427922 ∗ .5262953 ∗∗∗ -.135499
75- -.2268846 .3458703 ∗ .2762056
year dummy .5078101 ∗∗∗ .1382997 ∗∗∗
constant -1.225269 ∗∗∗ .2212076 ∗ 9.925178 ∗∗∗
Sample size 3003 755 2950
No. of households 1100 417
log likelihood ? -1819.9933 -3500.7883 0.0332†
p-value for Wald test ≤0.0001 ≤0.0001 ≤0.0001‡
Note: The estimation method for need in the yes/no indicator of outpatient
and inpatient is probit with random effects. For the number of outpatients or
inpatient days, the method is negative binominal with random effects. For OPP,
a heteroscedasticity-consistent linear model is used. † indicates R2 and ‡ indicates
the p-value for the F test. ∗∗∗ indicates significance at the 1% level, ∗∗ at the 5%
level , and ∗ at the 10% level. Since hospitalization days of ”Inpatienta” and
”Inpatientb” is surveyed only in 2003, the size of the sample is about half that
for other variables.
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Table3: Distribution by Income Quantile
Bottom 20% 20-40% 40-60% 60-80% Top 20%
Actual
Outpatient
Yes/No 11.1 10.2 9.29 10.4 10.9
Number .706 .753 .765 .717 .777
Inpatienta
Yes/No .044 .054 .064 .068 .055
Days 2.27 2.76 1.95 1.79 2.12
Inpatientb
Yes/No .438 .477 .487 .506 .493
Days 22.8 21.8 23.4 19.5 20.0
OPP 53410 57778 51650 66900 80577
Estimated
Outpatient
Yes/No 9.63 9.80 10.3 9.41 9.76
Number .835 .827 .824 .825 .820
Inpatienta
Yes/No .038 .033 .039 .031 .027
Days 1.59 2.36 3.07 2.68 2.66
Inpatientb
Yes/No .482 .475 .466 .482 .479
Days 48.6 51.6 49.4 52.8 50.8
OPP 62957 61969 63052 61736 61391
Note:
19
Table4: Concentration Index
Year Index p-
value
95% Lower
bound
95% Upper
bound
without regional dummies
Outpatient
Yes/No no .0133001 0.036 .0008926 .0257075
yes .0128394 0.043 .0004304 .0252484
Number no -.0014481 0.950 -.0466945 .0437982
yes -.003452 0.881 -.0484953 .0415914
Inpatienta
Yes/No no .0238123 0.561 -.0565128 .1041375
yes .0291438 0.478 -.0514387 .1097263
Days -.026409 0.841 -.2842658 .2314479
Inpatientb
Yes/No no .0207744 0.107 -.0045064 .0460552
yes .02566 0.042 .0009741 .050346
Days -.0195206 0.584 -.0894058 .0503645
OPP no .073927 0.001 .0319765 .1158776
yes .0748255 0.000 .0328541 .116797
with regional dummies
Outpatient
Yes/No no .0191708 0.004 .0061655 .032176
yes .0188095 0.005 .005814 .0318049
Number no -.0158913 0.506 -.0627827 .0310002
yes -.015044 0.529 -.0619071 .0318191
Inpatienta
Yes/No no .0199909 0.642 -.0643915 .1043734
yes .0181376 0.675 -.0665442 .1028194
Days -.0117427 0.926 -.2583283 .2348428
Inpatientb
Yes/No no .0321469 0.015 .0062303 .0580635
yes .0313325 0.018 .0054453 .0572196
Days .0080052 0.818 -.0602076 .076218
OPP no .065327 0.002 .0234634 .1071906
yes .0659555 0.002 .0238636 .1080474
Note: ”Year” indicates whether the estimated index takes year dummies into the
estimation equation.
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Table5: Kakwani Index
Year Index p-
value
95% Lower
bound
95% Upper
bound
without regional dummies
Outpatient
Yes/No no .0140893 0.024 .0018742 .0263043
yes .0141709 0.023 .0019533 .0263885
Number no .0011258 0.956 -.0393327 .0415844
yes .0002138 0.992 -.0400582 .0404858
Inpatienta
Yes/No no .0807551 0.046 .0013508 .1601594
yes .0794159 0.051 -.0003121 .1591439
Days -.1231977 0.182 -.304077 .0576816
Inpatientb
Yes/No no .0287579 0.021 .0043901 .0531256
yes .0279234 0.025 .0035536 .0522932
Days -.0232047 0.433 -.0811936 .0347842
OPP no -.0232047 0.433 -.0811936 .0347842
yes .0828898 0.000 .041062 .1247176
with regional dummies
Outpatient
Yes/No no .0201333 0.002 .0073386 .0329281
yes .0196416 0.003 .0068732 .03241
Number no -.009268 0.665 -.0512617 .0327258
yes -.0087318 0.683 -.0507228 .0332591
Inpatienta
Yes/No no .0770748 0.074 -.0075017 .1616514
yes .0758128 0.079 -.0088642 .1604898
Days -.0970992 0.279 -.2728992 .0787008
Inpatientb
Yes/No no .0374557 0.004 .0118865 .0630249
yes .0373853 0.004 .0118218 .0629489
Days -.0047643 0.868 -.061018 .0514893
OPP no .0739336 0.001 .0317866 .1160806
yes .0750902 0.001 .0327101 .1174704
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